The effect of early measles vaccination at 4.5 months of age on growth at 9 and 24 months of age in a randomized trial in Guinea-Bissau

BACKGROUND: Providing an early, additional measles vaccine (MV) at 4.5 months of age has been shown to reduce child mortality in low-income countries. We studied the effects on growth at 9 and 24 months of age. METHODS: A randomized controlled trial was conducted in Guinea-Bissau from 2003–2007 incl...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Pediatr
Asıl Yazarlar: Rasmussen, S. M., Biering-Sørensen, S., Byberg, S., Andersen, A., Bjerregaard-Andersen, M., Rodrigues, A., Benn, C. S., Martins, C. L., Aaby, P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2016
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5135799/
https://ncbi.nlm.nih.gov/pubmed/27912735
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12887-016-0738-z
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller